Stock listing

NASDAQ:CNCE Concert Pharmaceuticals Inc Stock

Follow Concert Pharmaceuticals Inc into a list and get an email when it puts out news.

Last close · NASDAQ:CNCE

$8.37 USD

Close on Mar 6, 2023 · No longer trades

Feb 13, 2014 to last close -41.0% · weekly closes, Feb 13, 2014 – Mar 6, 2023
Lowest – highest close
$2.69 – $29.05 USDSince Feb 13, 2014 · lowest Oct 22, 2021 · highest Dec 19, 2017

Delisted NASDAQ:CNCE no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:CNCE
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Concert Pharmaceuticals Inc on 6ix

Calls
7 calls with a replay · 7 with a transcript · latest Nov 7, 2022
Decks
4 decks · latest Aug 4, 2022

Events

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (August 2022)Investor deck22 slidesAug 4, 2022
Investor Presentation (May 2022)Investor deck17 slidesMay 23, 2022
Technical Presentation (September 2019)Technical20 slidesSep 5, 2019
Merger or Acquisition (April 2017)Merger or acquisition17 slidesApr 10, 2017

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Peter Barton Hutt
Other companies: Moderna, Inc. (Director · Dec 7, 2018 – Nov 20, 2019 · Past); Immunomedics Inc (Director · Mar 13, 2017 – Oct 23, 2020 · Past); Cartesian Therapeutics, Inc. (Director · Jun 21, 2016 – Jun 15, 2018 · Past); Seres Therapeutics, Inc. (Director · Jun 25, 2015 – Jun 15, 2016 · Past); Decoy Therapeutics Inc. (Director · Jan 28, 2015 – Jul 25, 2018 · Past); BIND Therapeutics Inc (Director · Sep 19, 2013 – Jun 21, 2016 · Past); Celera CORP (Director · Aug 19, 2008 – May 17, 2011 · Past); Ista Pharmaceuticals Inc (Director · Oct 19, 2006 – Jun 6, 2012 · Past); Momenta Pharmaceuticals Inc (Director · Jun 15, 2006 – Sep 12, 2014 · Past); CV Therapeutics Inc (Director · Jun 6, 2006 – May 31, 2007 · Past)
Director · Feb 12, 2014 – Mar 6, 2023 · Past
John G. Freund
Other companies: SI-BONE, Inc. (Director · Since at least Oct 16, 2018); Collegium Pharmaceutical, Inc. (Director · Since at least May 6, 2015); Sutro Biopharma, Inc. (Director · Sep 26, 2018 – Jun 6, 2024 · Past); Protara Therapeutics, Inc. (Director · Oct 21, 2014 – Nov 8, 2019 · Past); Tetraphase Pharmaceuticals Inc (Director · Mar 19, 2013 – Dec 10, 2019 · Past); Sirtris Pharmaceuticals Inc (Director · May 22, 2007 – May 29, 2007 · Past); Hansen Medical Inc (Director · Nov 15, 2006 – Jun 17, 2009 · Past); XenoPort Inc (Director · May 2, 2006 – Jul 5, 2016 · Past)
Director · Feb 12, 2014 – Feb 20, 2014 · Past
Wendall Wierenga
Other companies: Crinetics Pharmaceuticals, Inc. (Director · Since at least Jul 17, 2018); Cytokinetics, Incorporated (Director · Since at least Feb 9, 2011); Apricus Biosciences Inc (Director · Mar 10, 2014 – Jan 4, 2018 · Past); Ocera Therapeutics Inc (Director · Dec 19, 2013 – Dec 11, 2017 · Past); Santarus Inc (EVP, R&D · Jun 20, 2011 – Jan 2, 2014 · Past); XenoPort Inc (Director · May 7, 2009 – Jul 5, 2016 · Past); Onyx Pharmaceuticals Inc (Director · Dec 15, 2008 – Oct 1, 2013 · Past)
Director · Mar 13, 2014 – Jun 14, 2018 · Past
Meghan Fitzgerald
Other companies: Roivant Sciences Ltd. (Audit Committee Member, Nominating and Governance Committee Member · Since at least Mar 13, 2023); Tenet Healthcare Corporation (Director · Since at least May 25, 2018); Cardinal Health, Inc. (EVP, Strategy & Health Policy · May 18, 2015 – Nov 17, 2015 · Past); Vion Pharmaceuticals Inc (VP and Chief Business Officer · Jan 10, 2006 – Mar 12, 2007 · Past)
Director · Mar 22, 2016 – Jun 14, 2018 · Past
Richard Aldrich
Other companies: KalVista Pharmaceuticals, Inc. (Director · Nov 21, 2016 – Oct 3, 2018 · Past); PTC Therapeutics, Inc. (Director · Mar 7, 2013 – Jun 8, 2015 · Past); Tempest Therapeutics, Inc. (Director · Jun 11, 2012 – Dec 7, 2018 · Past); Verastem, Inc. (Director · Jan 26, 2012 – Jun 10, 2014 · Past)
Director · Feb 12, 2014 – Mar 6, 2023 · Past
James Cassella
Other companies: Trevi Therapeutics, Inc. (Chief Development Officer · Since at least Feb 13, 2020); Alexza Pharmaceuticals Inc (Former EVP, R&D and CSO, Director · Mar 8, 2006 – Jan 23, 2015 · Past)
Chief Development Officer · Feb 2, 2015 – Mar 6, 2023 · Past
Jesper Hoeiland
Other companies: Allarity Therapeutics, Inc. (Director · Since at least Jun 10, 2025); Radius Health, Inc. (President and CEO, Director · Jul 17, 2017 – Feb 20, 2020 · Past)
Director · Apr 29, 2019 – Mar 6, 2023 · Past
Ronald W Barrett
Other companies: Janux Therapeutics, Inc. (Director · Since at least Sep 7, 2021); XenoPort Inc (Chief Executive Officer, Director · Jan 31, 2006 – Sep 1, 2015 · Past)
Director · Feb 12, 2014 – Jun 10, 2021 · Past
Wilfred E Jaeger
Other companies: Neuronetics, Inc. (Director · Jun 27, 2018 – May 25, 2023 · Past); Nevro Corp (Director · Feb 27, 2018 – May 21, 2020 · Past)
Director · Jun 14, 2018 – Mar 6, 2023 · Past
Christi van Heek
Other companies: Affymax Inc (Director · Dec 6, 2007 – Jun 13, 2012 · Past)
Director · Apr 14, 2016 – Mar 6, 2023 · Past
All 21 people
PersonSeat
D Ryan Daws
Other companies: enGene Therapeutics Inc. (Chief Financial Officer · Since at least Nov 27, 2023)
Chief Financial Officer · Feb 12, 2014 – Jan 4, 2017 · Past
Helmut Schuhsler
Other companies: Enanta Pharmaceuticals, Inc. (Director · Mar 20, 2013 – Feb 21, 2014 · Past)
Director · Feb 12, 2014 – Jun 11, 2015 · Past
Jeffrey A Munsie
Other companies: Merrimack Pharmaceuticals Inc (General Counsel · Mar 31, 2017 – Dec 11, 2018 · Past)
Chief Legal Officer · Sep 23, 2019 – Mar 6, 2023 · Past
Lynette Herscha
Other companies: Solid Biosciences Inc. (Chief Legal Officer · Jan 30, 2019 – Jul 27, 2020 · Past)
General Counsel · Jun 1, 2017 – Mar 31, 2018 · Past
Nancy Stuart
Other companies: KalVista Pharmaceuticals, Inc. (Director · Since at least Mar 18, 2021)
Chief Operating Officer · Feb 12, 2014 – Mar 6, 2023 · Past
Roger D Tung
Other companies: Decoy Therapeutics Inc. (Director · Oct 30, 2017 – Jul 25, 2018 · Past)
Chief Executive Officer, Director · Feb 12, 2014 – Mar 6, 2023 · Past
Ryan Lynch
Other companies: Crescent Biopharma, Inc. (Senior Vice President, Finance and Chief Accounting Officer · Since at least Jun 13, 2025)
PAO · Jun 15, 2017 – Aug 15, 2019 · Past
Thomas G Auchincloss
Other companies: Metabolix Inc (CFO and VP · Nov 9, 2006 – Jun 28, 2007 · Past)
Director · Dec 11, 2014 – Mar 6, 2023 · Past
Marc A BeckerChief Financial Officer · Jan 4, 2018 – Mar 6, 2023 · Past
Pauline McGowanVP, Finance · Feb 12, 2014 – Jan 7, 2016 · Past
Robert SilvermanSenior VP, General Counsel · Feb 12, 2014 – Mar 13, 2017 · Past

Open People

Log in to ask 6ix AI your own questions about Concert Pharmaceuticals Inc.